Association of sleep disturbance and freezing of gait in Parkinson disease: prevention/delay implications
- PMID: 33231167
- PMCID: PMC8020700
- DOI: 10.5664/jcsm.9022
Association of sleep disturbance and freezing of gait in Parkinson disease: prevention/delay implications
Abstract
Study objectives: Freezing of gait (FOG) severely impairs life quality of Parkinson disease (PD) patients. The relationship between sleep disturbance and FOG in PD remains unclear, so in this study, we aimed to investigate that relationship.
Methods: First, we assessed clinical characteristics of freezers and nonfreezers among PD patients. Next, we assessed clinical characteristics of PD patients with different PDSS1 scores (score on first item of Parkinson's Disease Sleep Scale). Finally, we prospectively followed a cohort of nonfreezers from a baseline clinical visit and to a maximum of 18 months and performed a Cox regression analysis to further investigate the relationship between PDSS1 score and FOG in PD.
Results: A total of 163 participants with PD were included in the baseline analysis. The freezers had significantly worse sleep compared with the nonfreezers. The proportion of freezers in the patients with low PDSS1 score (PDSS1 < 6) was significantly higher than that in the patients with high PDSS1 score (PDSS1 ≥ 6). A total of 52 nonfreezers were prospectively followed. During a maximum 18-month follow-up, FOG incidence (73%) in the PDSS1 < 6 group was significantly higher than that (24%) in the PDSS1 ≥ 6 group (P = .008). Low PDSS1 score (hazard ratio = 4.23, 95% CI 1.64-10.92, P = .003) and high levodopa equivalent daily dose (hazard ratio = 4.18, 95% CI 1.62-10.75, P = .003) were significantly associated with an increased hazard of FOG.
Conclusions: Our study indicated that low PDSS1 score may be a risk indicator for the development of FOG and provided important insights into potential targets for the prevention/delay of FOG in PD.
Keywords: Parkinson disease; freezing of gait; levodopa; risk indicator; sleep disturbance.
© 2021 American Academy of Sleep Medicine.
Conflict of interest statement
All authors have seen and approved the manuscript. Institutions where work was conducted: Department of Neurology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. This study was funded by the Projects of the National Natural Science Foundation of China [grant number 81671273], [grant number 81171204], [grant number 30772280], [grant number 81400925], [grant number 81471148], [grant number 81771211], and [grant number 81703852]; the Project of Shanghai Municipal Education Commission of China [grant number 14YZ046]; the Project of Shanghai Municipal Health and Family Planning Commission of China [grant number 20134049], the Project of Shanghai Jiao Tong University of China [grant number YG2013MS22]; the Project of National Eastern Tech-transfer Center [grant number 201713972877]; the Projects of Shanghai Committee of Science and Technology [grant number 17401901000]; National Key R&D Program of China [grant number 2017YFC1310300]; SHSMU-ION Research Center for Brain Disorders [grant number 2015NKX007]. Jingyun Yang received research support from US National Institutes of Health grant nos. RF1AG015819, RF1AG052476, R01AG054058, and U01AG046152. The authors declare no conflicts of interest.
Figures


References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources